Compare ARK Genomic Revolution ETF (ARKG) vs iShares MSCI Australia ETF (EWA) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs iShares MSCI Australia ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while iShares MSCI Australia ETF trades at $28.43. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, iShares MSCI Australia ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | EWA | |
|---|---|---|
Sector | Sector/Thematic | Broad Market / Factor |
52-Week High | $43.57 | $30.26 |
52-Week Low | $23.09 | $24.95 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
EWA trades at $28.45 with a modest 0.89% daily gain, showing resilience amid overall bearish technical signals. The stock faces headwinds with bearish moving averages and neutral oscillators, while support and resistance cluster tightly around $28. Recent Australian economic developments, including GDP growth misses and fuel excise relief extensions, create a mixed backdrop for the company's operations.
The outlook remains cautious with technical indicators signaling bearish momentum, though the stock shows stability near current levels. Investment opportunities may emerge if the company demonstrates improved fundamentals, while risks include Australian economic volatility and competitive pressures in the regional market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About iShares MSCI Australia ETF
EWA tracks the MSCI Australia Index, providing broad exposure to large and mid-cap companies in the Australian equity market. It is structurally dominated by the financial and materials sectors, serving as a key instrument for investors seeking a single-country view of Australia's resource-rich and stable economy.
Read more on EWA →
